Epstein-Barr virus infection in humans: from harmless to life endangering virus-lymphocyte interactions - PubMed

Affiliations

• PMID: 17322915
• DOI: 10.1038/sj.onc.1210240

Review

Epstein-Barr virus infection in humans: from harmless to life endangering virus-lymphocyte interactions

E Klein et al. Oncogene. 2007.

Abstract

After the primary infection, that may or may not cause infectious mononucleosis, the ubiquitous Epstein-Barr virus (EBV) is carried for lifetime. The great majority of adult humans are virus carriers. EBV was discovered in a B-cell lymphoma (Burkitt lymphoma). EBV infection in humans is the example for the power of immune surveillance against virus transformed, potentially malignant cells. Although the virus can transform B lymphocytes in vitro into proliferating lines, it induces malignancy directly only in immunosuppressed hosts. EBV-induced growth transformation occurs only in B lymphocytes. It is the result of a complex interaction between virally encoded and cellular proteins. Different forms of the virus-cell and the cell-host interactions have evolved during a long period of coexistence between the virus and all Old World (but not New World) primates. The asymptomatic carrier state is based on a viral-strategy that downregulates the expression of the transforming proteins in the virus-carrying cell. In addition to the silent viral-gene carriers and the expressors of the nine virus-encoded genes that drive the growth program, virus carrying cells exist that show other patterns of gene expression, depending on the differentiated state of the host cell. Certain combinations contribute to malignant transformation, but only in conjunction with additional cellular changes. These are induced by direct or cytokine-mediated interactions with normal cells of the immune system.

Similar articles

• Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes.

  Klein G, Klein E, Kashuba E. Klein G, et al. Biochem Biophys Res Commun. 2010 May 21;396(1):67-73. doi: 10.1016/j.bbrc.2010.02.146. Biochem Biophys Res Commun. 2010. PMID: 20494113 Review.

• Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.

  Niller HH, Wolf H, Minarovits J. Niller HH, et al. Autoimmunity. 2008 May;41(4):298-328. doi: 10.1080/08916930802024772. Autoimmunity. 2008. PMID: 18432410 Review.

• Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1.

  Kis LL, Takahara M, Nagy N, Klein G, Klein E. Kis LL, et al. Immunol Lett. 2006 Apr 15;104(1-2):83-8. doi: 10.1016/j.imlet.2005.11.003. Epub 2005 Dec 1. Immunol Lett. 2006. PMID: 16386314 Review.

• [Expression of ZEBRA protein of Epstein-Barr virus in Hungarian patients with Hodgkin lymphoma: latent or lytic cycle?].

  Beck Z, Illés A, Keresztes K, Bessenyei B, Szöllosi Z, Kis A, Oláh E. Beck Z, et al. Orv Hetil. 2006 Aug 20;147(33):1539-44. Orv Hetil. 2006. PMID: 17037676 Hungarian.

• Epstein-Barr virus and oncogenesis: from latent genes to tumours.

  Young LS, Murray PG. Young LS, et al. Oncogene. 2003 Aug 11;22(33):5108-21. doi: 10.1038/sj.onc.1206556. Oncogene. 2003. PMID: 12910248 Review.

Cited by

• EBV genome carrying B lymphocytes that express the nuclear protein EBNA-2 but not LMP-1: Type IIb latency.

  Klein E, Nagy N, Rasul AE. Klein E, et al. Oncoimmunology. 2013 Feb 1;2(2):e23035. doi: 10.4161/onci.23035. Oncoimmunology. 2013. PMID: 23526738 Free PMC article.

• Pediatric post-transplant lymphoproliferative disorder after cardiac transplantation.

  Ohta H, Fukushima N, Ozono K. Ohta H, et al. Int J Hematol. 2009 Sep;90(2):127-136. doi: 10.1007/s12185-009-0399-x. Epub 2009 Aug 12. Int J Hematol. 2009. PMID: 19669857 Review.

• Silencing viral microRNA as a novel antiviral therapy?

  Moens U. Moens U. J Biomed Biotechnol. 2009;2009:419539. doi: 10.1155/2009/419539. Epub 2009 May 28. J Biomed Biotechnol. 2009. PMID: 19704916 Free PMC article. Review.

• Viruses associated with human cancer.

  McLaughlin-Drubin ME, Munger K. McLaughlin-Drubin ME, et al. Biochim Biophys Acta. 2008 Mar;1782(3):127-50. doi: 10.1016/j.bbadis.2007.12.005. Epub 2007 Dec 23. Biochim Biophys Acta. 2008. PMID: 18201576 Free PMC article. Review.

• A study of Epstein-Barr virus infection in the Chinese tree shrew(Tupaia belangeri chinensis).

  Wang Z, Yi X, Du L, Wang H, Tang J, Wang M, Qi C, Li H, Lai Y, Xia W, Tang A. Wang Z, et al. Virol J. 2017 Oct 6;14(1):193. doi: 10.1186/s12985-017-0859-5. Virol J. 2017. PMID: 28985762 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database